Viewing Study NCT06208735

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:19 PM
Ignite Modification Date: 2026-06-04 @ 6:52 PM
Study NCT ID: NCT06208735
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2023-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Sponsor: British Columbia Cancer Agency
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Leukemia View
None Non-Hodgkin's Lymphoma View
None B-cell Acute Lymphoblastic Leukemia View
None Diffuse Large B Cell Lymphoma View
None High-grade B-cell Lymphoma View
None Primary Mediastinal Large B-cell Lymphoma (PMBCL) View
None Mantle Cell Lymphoma View
None B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chimeric Antigen Receptor T cells View
None CLIC-2201 View
None CD22 View
None Immunotherapy View
None CAR-T cell View